newsfilter
← Latest News
GlobeNewswire·

miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates

Recently completed acquisition of Viridian Therapeutics, including an anti-IGF-1R monoclonal antibody, VRDN-001, for the potential treatment of thyroid eye disease (TED)Private placement financing...